603 Targeted STAT3 degradation leads to remodeling of an immunosuppressive tumor microenvironment and subsequent sensitization to immune checkpoint therapy

• Bin Yang,
• Jared Gollob,
• Joyoti Dey,
• Phillip Liu,
• Michele Mayo,
• Rahul Karnik,
• Vaishali Dixit,
• Jieun Jeong,
• Chris De Savi

Affiliations

Bin Yang

2 Department of Anaesthesiology, Chongqing University Cancer Hospital, Chongqing, China

Jared Gollob

9 Alnylam Pharmaceuticals, Cambridge USA

Joyoti Dey

Kymera Therapeutics, Watertown, MA, USA

Phillip Liu

Kymera Therapeutics, Watertown, MA, USA

Michele Mayo

Kymera Therapeutics, Watertown, MA, USA

Rahul Karnik

Kymera Therapeutics, Watertown, MA, USA

Vaishali Dixit

Kymera Therapeutics, Watertown, MA, USA

Jieun Jeong

Kymera Therapeutics, Watertown, MA, USA

Chris De Savi

Kymera Therapeutics, Watertown, MA, USA